A single dose of the psychedelic drug dimethyltryptamine (DMT) had a rapid and sustained effect on depressive symptoms in a small trial. DMT – a fast-acting and extremely potent psychedelic found in ...

Fractal Analytics IPO listing: The shares of Fractal Analytics will make their stock market debut on Monday, February 16, after the mainboard IPO received a moderate response from investors during the ...

As India’s first AI company to IPO, Fractal Analytics didn’t have a stellar first day on the public markets, as enthusiasm for the technology collided with jittery investors recovering from a major ...

It’s not easy to distinguish one wireless headset from another in such a crowded current marketplace in the $150-$200 bracket, but case specialist Fractal has shown a typically considered approach to ...

Disclosuree Michiel van Elk receives funding from the Netherlands Organization for Scientific Research (NWO; grant id# VI.Vidi.191.107). He is affiliated as board member with Open Foundation ...

Study finds participants saw reduction in depressive symptoms as researchers welcome ‘promising’ results A phase II clinical trial has found dimethyltryptamine (DMT), one of the psychoactive ...

Fractal Industries IPO: The initial public offering (IPO) of Fractal Analytics, which is engaged in the garment design and manufacturing activities, kicked off for bidding on Monday, February 16, ...

FOR FIVE years biotech startups have been betting that psychedelic substances could be turned into real medicines. One of them may have hit the jackpot. On February 17th Compass Pathways, a British ...

The initial public offering (IPO) of Fractal Analytics had garnered a moderate response from investors during its three-day subscription period. Fractal has scaled down the size of its IPO from the Rs ...

Researchers find DMT – used in shamanic rituals – in tandem with psychotherapy has significant effect People with major depressive disorder can see a rapid and lasting improvement after a single dose ...

We initiate coverage on Fractal with ‘BUY’ rating and TP of Rs1,260, valuing at 22x EV/EBITDA FY28E, with potential upside of 40%. Fractal operates in the analytics space that powers decision making ...